Study Subject Participation Status Consent
Item
1. subjects who have volunteered and consented to participate in the study.
boolean
C2348568 (UMLS CUI [1,1])
C1511481 (UMLS CUI [1,2])
Medical contraindication Absent | Prednisone Oral Product High dose | Acthar Oral High dose
Item
2. subjects who have no contraindication to taking high dose, oral prednisone or acthar.
boolean
C1301624 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C3216040 (UMLS CUI [2,1])
C0444956 (UMLS CUI [2,2])
C0718234 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0444956 (UMLS CUI [3,3])
Age
Item
3. male or female subjects age 18 or greater years of age.
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting
Item
4. subjects with relapsing remitting multiple sclerosis (rrms) based on 2010 mcdonald criteria.
boolean
C0751967 (UMLS CUI [1])
Communicable Disease Absent | Antibiotics Urinary tract infection Uncomplicated
Item
5. subjects without an active infection (note: if a patient is found to have an uncomplicated uti and agrees to start on appropriate antibiotic treatment, they can continue in the study).
boolean
C0009450 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0003232 (UMLS CUI [2,1])
C0042029 (UMLS CUI [2,2])
C0443334 (UMLS CUI [2,3])
Multiple sclerosis relapse
Item
6. subjects who are experiencing a protocol defined ms relapse within two weeks of relapse onset.
boolean
C0856120 (UMLS CUI [1])
Informed Consent
Item
7. subjects who are able and willing to sign a consent form.
boolean
C0021430 (UMLS CUI [1])
Age
Item
1. subjects who are less than 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Medical contraindication Acthar
Item
2. subjects with any contraindication to taking acthar.
boolean
C1301624 (UMLS CUI [1,1])
C0718234 (UMLS CUI [1,2])
Communicable Disease | Exception Urinary tract infection Uncomplicated | Exception Antibiotics Urinary tract infection
Item
3. subjects with an active infection other than an uncomplicated urinary tract infection (uti) (subjects determined to have a uti who agree to be treated with appropriate antibiotics will not be excluded).
boolean
C0009450 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0042029 (UMLS CUI [2,2])
C0443334 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0003232 (UMLS CUI [3,2])
C0042029 (UMLS CUI [3,3])
Immunodeficiency
Item
4. subjects with an immune deficiency.
boolean
C0021051 (UMLS CUI [1])
Gastrointestinal ulcer | Diabetes Mellitus | Gestational Diabetes | Malignant Hypertension | PSYCHOSIS STEROID INDUCED
Item
5. subjects with a history of any of the following conditions: gastrointestinal ulcers, diabetes mellitus, gestational diabetes, malignant hypertension or steroid induced psychosis.
boolean
C0237938 (UMLS CUI [1])
C0011849 (UMLS CUI [2])
C0085207 (UMLS CUI [3])
C0020540 (UMLS CUI [4])
C0748068 (UMLS CUI [5])
Pregnancy | Breast Feeding
Item
6. subjects who are pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Informed Consent Unable | Informed Consent Unwilling
Item
7. subjects who are unable or unwilling to sign consent form.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Phone follow-up Unable | Phone follow-up Unwilling | Follow-up Unable | Follow-up Unwilling
Item
8. patient is unable or unwilling to participate in phone and clinic follow up.
boolean
C1705541 (UMLS CUI [1,1])
C1522577 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C1705541 (UMLS CUI [2,1])
C1522577 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
C1522577 (UMLS CUI [3,1])
C1299582 (UMLS CUI [3,2])
C1522577 (UMLS CUI [4,1])
C0558080 (UMLS CUI [4,2])
Factor Study Subject Participation Status Excluded
Item
9. other factors that in the opinion of the principal investigator would exclude the subject from participation in the study.
boolean
C1521761 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])